Skip to main content

BLU-667 100 mg (Gavreto 100 mg)

Generic Name: pralsetinib

Pill with imprint BLU-667 100 mg is Blue, Capsule-shape and has been identified as Gavreto 100 mg. It is supplied by Genentech, Inc..

Gavreto is used in the treatment of non-small cell lung cancer; thyroid cancer and belongs to the drug class multikinase inhibitors. Gavreto 100 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for BLU-667 100 mg

Gavreto 100 mg BLU-667 100 mg

Gavreto

Generic Name
pralsetinib
Imprint
BLU-667 100 mg
Strength
100 mg
Color
Blue
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Multikinase inhibitors
CSA Schedule
Not a controlled drug
Labeler / Supplier
Genentech, Inc.
National Drug Code (NDC)
72064-0210

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.